SHAREHOLDERS' DEFICIT (Tables)

9 Months Ended

Mar. 24, 2021

Stockholders' Equity Note [Abstract]

Changes in Shareholders' Deficit Schedule

The changes in Total shareholders’ deficit during the thirty-nine week periods ended March 24, 2021 and March 25, 2020, respectively, were as follows:

	Thirty-Nine Week Period Ended March 24, 2021
	Common Stock		Additional Paid-In Capital		Accumulated Deficit		Treasury Stock		Accumulated Other Comprehensive Loss		Total
Balance at June 24, 2020	$	7.0	$	669.4	$	(397.5)	$	(751.8)	$	(6.2)	$	(479.1)
Net income	—		—		10.7		—		—		10.7
Other comprehensive income	—		—		—		—		0.3		0.3
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		3.9		—		—		—		3.9
Purchases of treasury stock	—		(1.1)		—		(2.8)		—		(3.9)
Issuances of common stock	—		(9.0)		—		12.0		—		3.0
Balance at September 23, 2020	$	7.0	$	663.2	$	(386.8)	$	(742.6)	$	(5.9)	$	(465.1)
Net income	—		—		12.0		—		—		12.0
Other comprehensive income	—		—		—		—		0.5		0.5
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		3.0		—		—		—		3.0
Purchases of treasury stock	—		0.0		—		0.0		—		0.0
Issuances of common stock	—		1.2		—		4.3		—		5.5
Balance at December 23, 2020	$	7.0	$	667.4	$	(374.8)	$	(738.3)	$	(5.4)	$	(444.1)
Net income	—		—		33.9		—		—		33.9
Other comprehensive income	—		—		—		—		0.3		0.3
Dividends	—		—		0.0		—		—		0.0
Stock-based compensation	—		4.4		—		—		—		4.4
Purchases of treasury stock	—		(0.1)		—		(0.1)		—		(0.2)
Issuances of common stock	—		5.7		—		9.4		—		15.1
Balance at March 24, 2021	$	7.0	$	677.4	$	(340.9)	$	(729.0)	$	(5.1)	$	(390.6)

	Thirty-Nine Week Period Ended March 25, 2020
	Common Stock		Additional Paid-In Capital		Retained Earnings (Accumulated Deficit)		Treasury Stock		Accumulated Other Comprehensive Loss		Total
Balance at June 26, 2019	$	17.6	$	522.0	$	2,771.2	$	(4,083.4)	$	(5.6)	$	(778.2)
Effect of ASC 842 adoption	—		—		195.9		—		—		195.9
Net income	—		—		14.9		—		—		14.9
Other comprehensive loss	—		—		—		—		(0.2)		(0.2)
Dividends ($0.38 per share)	—		—		(14.6)		—		—		(14.6)
Stock-based compensation	—		7.1		—		—		—		7.1
Purchases of treasury stock	—		(0.3)		—		(11.0)		—		(11.3)
Issuances of common stock	—		(3.7)		—		5.0		—		1.3
Balance at September 25, 2019	$	17.6	$	525.1	$	2,967.4	$	(4,089.4)	$	(5.8)	$	(585.1)
Net income	—		—		27.9		—		—		27.9
Other comprehensive income	—		—		—		—		0.1		0.1
Dividends ($0.38 per share)	—		—		(14.6)		—		—		(14.6)
Stock-based compensation	—		2.6		—		—		—		2.6
Purchases of treasury stock	—		0.0		—		0.0		—		0.0
Issuances of common stock	—		(0.4)		—		0.6		—		0.2
Retirement of treasury stock	(11.4)		—		(3,345.4)		3,356.8		—		—
Balance at December 25, 2019	$	6.2	$	527.3	$	(364.7)	$	(732.0)	$	(5.7)	$	(568.9)
Net income	—		—		30.8		—		—		30.8
Other comprehensive loss	—		—		—		—		(1.0)		(1.0)
Dividends ($0.38 per share)	—		—		(14.0)		—		—		(14.0)
Stock-based compensation	—		(0.7)		—		—		—		(0.7)
Purchases of treasury stock	—		0.0		—		(21.0)		—		(21.0)
Issuances of common stock	—		(0.5)		—		0.6		—		0.1
Balance at March 25, 2020	$	6.2	$	526.1	$	(347.9)	$	(752.4)	$	(6.7)	$	(574.7)

Stock-based Compensation Schedule

The following table presents the stock options and restricted share awards granted, and related weighted average exercise price and fair value per share amounts.

	Thirty-Nine Week Periods Ended
	March 24, 2021		March 25, 2020
Stock options
Stock options granted	—		0.3
Weighted average exercise price per share	$	—	$	38.51
Weighted average fair value per share	$	—	$	6.83
Restricted share awards
Restricted share awards granted	0.5		0.3
Weighted average fair value per share	$	40.49	$	38.68